PMID: 6170985Sep 1, 1981Paper

Control of expression of histocompatibility antigens (H-2) and beta 2-microglobulin in F9 teratocarcinoma stem cells

Proceedings of the National Academy of Sciences of the United States of America
C M CroceJ G Seidman

Abstract

Murine teratocarcinoma stem cells, unlike most other cell types, do not express major histocompatibility antigens. The steady-state levels of beta 2-microglobulin and H-2 mRNA from F9-derived teratocarcinoma stem and differentiated cells were examined by blot hybridization using cloned DNA probes specific for these mRNAs. No H-2- or beta 2-microglobulin-specific RNA was detected in F9 teratocarcinoma stem cells (clone 12-1); thus, F9 teratocarcinoma stem cells (clone 12-1) contain no more than 1/10 the H-2 and beta 2-microglobulin mRNAs of the differentiated daughter cells (clone 12-1a). We suggest that this regulation of major histocompatibility antigen expression is due to transcriptional control of the major histocompatibility antigen genes, H-2 and beta 2-microglobulin. The transcriptional regulation of these genes is accompanied by a change in their DNase I sensitivity. Normally, transcriptionally inactive genes are DNase I resistant, while active genes are DNase I sensitive. In contrast, the silent major histocompatibility antigen genes of teratocarcinoma stem cells are more DNase I sensitive than the active genes of the differentiated cells.

References

Sep 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·J Forman, E S Vitetta
Dec 21, 1978·Nature·J G Seidman, P Leder
Dec 1, 1979·Cell·D H Hamer, P Leder
Nov 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·S Segal, G Khoury
Nov 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·D Solter, B B Knowles
Sep 3, 1976·Science·H Weintraub, M Groudine
Nov 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·A Garel, R Axel
Jun 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·H Aviv, P Leder
Dec 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·E G BerstineB Ephrussi
Feb 1, 1973·Transplantation·H Patthey, M Edidin
Jun 4, 1974·Biochemistry·V GlisinC Byus
Jun 1, 1971·The Journal of Experimental Medicine·J PalmR L Brinster
Sep 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·P S Thomas
Apr 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·J R ParnesJ G Seidman
Aug 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·A LinnenbachC M Croce
Aug 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·K HuebnerC M Croce
Jun 1, 1980·The Journal of Experimental Medicine·R GmürB B Knowles

❮ Previous
Next ❯

Citations

Jan 1, 1983·American Journal of Industrial Medicine·J Dean
Jan 1, 1987·Immunogenetics·S Ostrand-Rosenberg, V Clements
Jan 1, 1983·Immunogenetics·L L JohnsonA Shedlovsky
Jan 1, 1985·Immunogenetics·F Daniel-VedeleP Kourilsky
Jan 1, 1985·Immunogenetics·P Démant, M Oudshoorn-Snoek
Dec 1, 1984·Cell Differentiation·S Ostrand-RosenbergM Schwartzman
Apr 29, 1982·Biochimica Et Biophysica Acta·F Kelly, H Condamine
Jun 1, 1990·Biochimica Et Biophysica Acta·S Goodbourn
Oct 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·A LinnenbachC M Croce
Dec 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·D MerueloA Rossomando
Apr 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·P Brûlet, F Jacob
Sep 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·K TanakaE Appella
Apr 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·A RazinH Cedar
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·D MerueloA L Mellor
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J MiyazakiK Ozato
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·A IsraëlP Kourilsky
Jan 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·G J LaRosa, L J Gudas
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·S Ostrand-RosenbergI Stroynowski
Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·B H Koller, O Smithies
Oct 1, 1983·The Journal of Experimental Medicine·P BaldacciP Kourilsky
Feb 1, 1985·The Journal of Experimental Medicine·J H Weis, C Murre
Jan 1, 1989·The Journal of Experimental Medicine·F Momburg, S Koch
Jun 1, 1992·European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics·G NavaG Alfaro
Jul 1, 1985·The Journal of Clinical Investigation·K E SullivanB M Peterlin
May 10, 2003·Proceedings of the National Academy of Sciences of the United States of America·Hiroshi KubotaRalph L Brinster

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.